Pituitary gonadotropin inhibitory activity of danazol

MeSH descriptors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (10)

• Clinical studies with an antigonadotropin-Danazol via openalex
• Danazol--a synthetic steroid derivative with interesting physiologic properties via openalex
• Pituitary and testicular function studies. I. Experience with a new gonadal inhibitor, 17-alpha-pregn-4-en-20-yno-(2,3-d)isoxazol-17-ol (Danazol) via openalex
• The treatment of endometriosis with Danazol via openalex
• doi:10.1021/jm00337a001 via openalex
• doi:10.1098/rspb.1937.0004 via openalex
• doi:10.1152/physrev.1945.25.2.203 via openalex
• doi:10.3181/00379727-83-20301 via openalex
• doi:10.1113/jphysiol.1934.sp003217 via openalex
• doi:10.1210/endo-24-1-35 via openalex

Cited by (50)

• Microbial transformation of danazol with Cunninghamella blakesleeana and anti-cancer activity of danazol and its transformed products 2015
• Reversible inhibition of spermatogenesis by danazol with combination of testosterone enanthate in rabbit 2009
• Danazol regulates the functions of normal human endometrial stromal cell subpopulations by modifying endometrial cytokine networks 2009
• A benefit-risk assessment of medical treatment for uterine leiomyomas 2002
• Danazol enhances Fas-mediated apoptosis in human endometrial epithelial cells within normal physiology 1998
• Pain recurrence: a quality of life issue in endometriosis 1995
• Goserelin (Zoladex) versus danazol for endometriosis: the North American experience 1994
• Effects of danazol on DNA synthesis in rat prostate 1993
• The effect of danazol on tumour control and weight loss in patients on tamoxifen therapy for advanced breast cancer: a randomised double-blind placebo controlled trial 1993
• Effects of danazol on endometrial DNA synthesis in rats 1993
• Inhibitory and stimulatory actions of danazol in rat ovarian and uterine tissues 1992
• Suppression of the development of uterine adenomyosis by danazol treatment in mice 1992
• Progesterone receptor induction by danazol in cultured cancer cells and the rat uterus 1992
• Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component 1989
• Inhibition of gonadotropin-releasing hormone receptors in rat anterior pituitary monolayer cell cultures by danazol 1986
• Danazol and fetal masculinization: a warning 1985
• Danazol treatment of endometriosis: long-term follow-up 1985
• Danazol binding to steroid receptors in human uterine endometrium 1984
• Short-term effects of danazol on endometrial histology 1984
• Effect of danazol on serum concentrations of pituitary gonadotropins in postmenopausal women 1984
• The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle 1983
• Effects of ethinylestradiol and danazol on embryo survival and implantation in mated beagle bitches 1983
• Danazol 1982
• Effect of danazol on gonadal steroidogenesis in patients with a complete form of testicular feminization 1982
• In vitro effect of danazol on luteinizing hormone-releasing hormone-stimulated luteinizing hormone release in rat anterior pituitary cell cultures in vitro 1981
• Actions of danazol in vivo on cytochrome P-450 and steroidogenic enzymes in rat testis and liver microsomal preparations 1981
• Danazol suppression of luteinizing hormone secretion: a role for danazol-androgen receptor interaction within the brain-pituitary complex 1981
• Transient adrenogenital syndrome due to exposure to danazol in utero 1981
• Changes of prolactin secretion following long-term danazol application 1981
• Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness 1981
• Cholesterol, high density lipoprotein and danazol 1981
• Pharmacology and pharmacokinetics of danazol 1980
• Review: The mechanism of action of danazol, a novel steroid derivative 1980
• Competitive inhibition by danazol of oestradiol binding to rabbit and ovine uterine oestradiol receptor 1980
• Evidence that danazol inhibits gonadotropin-induced ovarian steroidogenesis at a point distal to gonadotropin-receptor interaction and adenosine 3',5' cyclic monophosphate formation 1980
• Inhibition of adrenal steroidogenesis by danazol in vivo 1980
• Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biologic activity 1979
• Danazol increasingly used. 1979
• Increased accumulation of estrogen receptors in pituitary nuclei of danazol treated rats 1979
• A radioimmumoassay for danazol (17α-Pregna-2,4-Dien-20-Yno[2,3-d]Isoxazol-17-OL) 1978
• Effects of danazol on gonadotropin secretion after ovariectomy in rats 1978
• Fertility in the rhesus monkey following long-term inhibition of ovarian function with danazol 1978
• Radioimmunoassay for danazol in human and monkey plasma 1978
• Danazol effects on gonadotropin basal levels and pituitary responsiveness to LH-RH in immature male rats 1978
• Effects of Danazol on pituitary gonadotrophins in post-menopausal women 1978
• Danazol: an antigonadotrophic agent in the treatment of recurrent pelvic and intestinal endometriosis 1977
• Danazol therapy in hormone-sensitive mammary carcinoma 1977
• Danazol Inhibits Steroidogenesis 1977
• The effect of danazol on anterior pituitary function 1977
• Progestational activity of danazol in the human female subject 1976

Source provenance

openalex

last seen: 2026-05-14T06:16:54.145842+00:00

pubmed

last seen: 2026-10-08T21:57:27.106718+00:00

unpaywall

last seen: 2026-09-17T06:32:46.214484+00:00